{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:50:10Z","timestamp":1791312610163,"version":"4.3.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004360"],"award-info":[{"award-number":["UM1TR004360"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA053507"],"award-info":[{"award-number":["K23DA053507"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007027"],"award-info":[{"award-number":["T32DA007027"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F30DA057047"],"award-info":[{"award-number":["F30DA057047"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA050207"],"award-info":[{"award-number":["UG1DA050207"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R00DA045765"],"award-info":[{"award-number":["R00DA045765"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>Insomnia symptoms are negatively related to opioid use disorder (OUD) treatment outcomes, possibly reflecting the influence of sleep on neurofunctional domains implicated in addiction. Moreover, the intersection between OUD recovery and sleep represents an area well-suited for the development of novel, personalized treatment strategies. This study assessed the prevalence of clinically significant insomnia symptoms and characterized its neurofunctional correlates among a clinical sample of adults with OUD receiving buprenorphine.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Adults (N = 129) receiving buprenorphine for OUD from an outpatient clinic participated in a cross-sectional survey. Participants completed an abbreviated version of NIDA\u2019s Phenotyping Assessment Battery, which assessed 6 neurofunctional domains: sleep, negative emotionality, metacognition, interoception, cognition, and reward. Bivariate descriptive statistics compared those with evidence of clinically significant insomnia symptoms (Insomnia Severity Index [ISI] score of \u226511) to those with minimal evidence of clinically significant insomnia symptoms (ISI score of \u226410) across each of the neurofunctional domains.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Roughly 60% of participants reported clinically significant insomnia symptoms (ISI score of \u226511). Experiencing clinically significant insomnia symptoms was associated with reporting greater levels of depression, anxiety, post-traumatic stress, stress intolerance, unhelpful metacognition, and interoceptive awareness (ps&lt;0.05). Participants with evidence of clinically significant insomnia were more likely to report that poor sleep was interfering with their OUD treatment and that improved sleep would assist with their treatment (ps&lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Insomnia was prevalent among adults receiving buprenorphine for OUD. Insomnia was associated with neurofunctional performance, which may impact OUD treatment trajectories. Our findings indicate potential targets in the development of personalized treatment plans for patients with co-morbid insomnia and OUD. To inform the development of novel treatment strategies, more research is needed to understand the potential mechanistic links between sleep disturbances and substance use.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0304461","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:32:39Z","timestamp":1718299959000},"page":"e0304461","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7794-1253","authenticated-orcid":true,"given":"Augustus M.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Eglovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Beth","family":"Parlier-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Dzierzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-8607","authenticated-orcid":true,"given":"Morgan","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0593-3291","authenticated-orcid":true,"given":"James M.","family":"Bjork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Gerard","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-458X","authenticated-orcid":true,"given":"Caitlin E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"1","key":"pone.0304461.ref001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41386-019-0465-x","article-title":"Drugs, sleep, and the addicted brain","volume":"45","author":"RJ Valentino","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"pone.0304461.ref002","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11920-014-0487-3","article-title":"Sleep and substance use disorders: an update","volume":"16","author":"DA Conroy","year":"2014","journal-title":"Curr Psychiatry Rep"},{"key":"pone.0304461.ref003","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trsl.2021.03.006","article-title":"At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities","volume":"234","author":"MK Greenwald","year":"2021","journal-title":"Transl Res"},{"key":"pone.0304461.ref004","doi-asserted-by":"crossref","first-page":"173153","DOI":"10.1016\/j.pbb.2021.173153","article-title":"Sleep and alertness disturbance and substance use disorders: A bi-directional relation","volume":"203","author":"T Roehrs","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"pone.0304461.ref005","first-page":"140","article-title":"Crosstalk between Sleep Disturbance and Opioid Use Disorder: A Narrative Review","volume":"12","author":"HR Fathi","year":"2020","journal-title":"Addict Health"},{"issue":"2","key":"pone.0304461.ref006","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ccm.2022.05.001","article-title":"Sleep Deficiency and Opioid Use Disorder: Trajectory, Mechanisms, and Interventions","volume":"43","author":"J Langstengel","year":"2022","journal-title":"Clinics in chest medicine"},{"key":"pone.0304461.ref007","unstructured":"Eglovitch M, Parlier-Ahmad AB, Legge C, Chithranjan S, Kolli S, Violante S, et al. Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder. (1664\u20130640 (Print))."},{"key":"pone.0304461.ref008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsat.2019.06.003","article-title":"Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program","volume":"104","author":"AK Wilkerson","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"pone.0304461.ref009","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1037\/pha0000477","article-title":"Sleep disturbance as a therapeutic target to improve opioid use disorder treatment","volume":"30","author":"AS Huhn","year":"2022","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"pone.0304461.ref010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.sleep.2018.08.015","article-title":"Pain intensity as a moderator of the association between opioid use and insomnia symptoms among adults with chronic pain","volume":"52","author":"MB Miller","year":"2018","journal-title":"Sleep Med"},{"key":"pone.0304461.ref011","doi-asserted-by":"crossref","first-page":"101205","DOI":"10.1016\/j.smrv.2019.07.008","article-title":"Insomnia and cognitive performance: A systematic review and meta-analysis","volume":"48","author":"S Wardle-Pinkston","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"5","key":"pone.0304461.ref012","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/15298868.2018.1478324","article-title":"Self-control \u201cin the wild\u201d: Experience sampling study of trait and state self-regulation","volume":"18","author":"RF Baumeister","year":"2019","journal-title":"Self and Identity"},{"key":"pone.0304461.ref013","doi-asserted-by":"crossref","unstructured":"Fragale JE, James MH, Avila JA, Spaeth Andrea M, Aurora RN, Langleben D, et al. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System. The Orexin System Basic Science and Role in Sleep Pathology. Frontiers of Neurology and Neuroscience2021. p. 117\u201327.","DOI":"10.1159\/000514965"},{"issue":"5","key":"pone.0304461.ref014","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41386-020-0619-x","article-title":"Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?","volume":"45","author":"MH James","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"pone.0304461.ref015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-012-2689-x","article-title":"Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction","volume":"221","author":"WK Bickel","year":"2012","journal-title":"Psychopharmacology"},{"issue":"1","key":"pone.0304461.ref016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1037\/mot0000258","article-title":"Poor sleep quality is significantly associated with effort but not temporal discounting of monetary rewards","volume":"8","author":"EM Boland","year":"2022","journal-title":"Motivation Science"},{"key":"pone.0304461.ref017","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2015.00284","article-title":"Interactions between sleep habits and self-control","volume":"9","author":"JJ Pilcher","year":"2015","journal-title":"Frontiers in Human Neuroscience"},{"issue":"23","key":"pone.0304461.ref018","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"JL Jameson","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0304461.ref019","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/appi.ajp.2019.19121284","article-title":"Personalizing the Treatment of Substance Use Disorders","volume":"177","author":"ND Volkow","year":"2020","journal-title":"American Journal of Psychiatry"},{"key":"pone.0304461.ref020","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1041433","article-title":"Restoring the missing person to personalized medicine and precision psychiatry","volume":"17","author":"A G\u00f3mez-Carrillo","year":"2023","journal-title":"Frontiers in Neuroscience"},{"key":"pone.0304461.ref021","unstructured":"Parlier-Ahmad AA-O, Eglovitch M, Legge C, Keyser-Marcus LA, Bjork JM, Adams A, et al. Development and clinical feasibility study of a brief version of an addiction-focused phenotyping battery in females receiving buprenorphine for opioid use disorder. (2162\u20133279 (Electronic))."},{"issue":"4","key":"pone.0304461.ref022","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"CH Bastien","year":"2001","journal-title":"Sleep Medicine"},{"issue":"5","key":"pone.0304461.ref023","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"CM Morin","year":"2011","journal-title":"Sleep"},{"key":"pone.0304461.ref024","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.sleep.2020.08.027","article-title":"ISI-3: evaluation of a brief screening tool for insomnia","volume":"82","author":"M Thakral","year":"2021","journal-title":"Sleep Med"},{"issue":"2","key":"pone.0304461.ref025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11031-005-7955-3","article-title":"The Distress Tolerance Scale: Development and validation of a self-report measure","volume":"29","author":"JS Simons","year":"2005","journal-title":"Motivation and Emotion"},{"issue":"9","key":"pone.0304461.ref026","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"K Kroenke","year":"2001","journal-title":"Journal of General Internal Medicine"},{"issue":"10","key":"pone.0304461.ref027","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7","volume":"166","author":"RL Spitzer","year":"2006","journal-title":"Archives of internal medicine"},{"issue":"7","key":"pone.0304461.ref028","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"RD Hays","year":"2009","journal-title":"Qual Life Res"},{"issue":"6","key":"pone.0304461.ref029","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation","volume":"28","author":"CA Blevins","year":"2015","journal-title":"Journal of Traumatic Stress"},{"issue":"3","key":"pone.0304461.ref030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The Aggression Questionnaire","volume":"63","author":"AH Buss","year":"1992","journal-title":"Journal of personality and social psychology"},{"issue":"1","key":"pone.0304461.ref031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A Scale for the Assessment of Hedonic Tone the Snaith\u2014Hamilton Pleasure Scale","volume":"167","author":"RP Snaith","year":"1995","journal-title":"The British Journal of Psychiatry"},{"issue":"4","key":"pone.0304461.ref032","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0005-7967(03)00147-5","article-title":"A short form of the metacognitions questionnaire: properties of the MCQ-30","volume":"42","author":"A Wells","year":"2004","journal-title":"Behaviour Research and Therapy"},{"issue":"11","key":"pone.0304461.ref033","doi-asserted-by":"crossref","first-page":"e48230","DOI":"10.1371\/journal.pone.0048230","article-title":"The Multidimensional Assessment of Interoceptive Awareness (MAIA)","volume":"7","author":"WE Mehling","year":"2012","journal-title":"PLOS ONE"},{"issue":"3","key":"pone.0304461.ref034","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1037\/a0035973","article-title":"A 5-trial adjusting delay discounting task: Accurate discount rates in less than one minute","volume":"22","author":"MN Koffarnus","year":"2014","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"9","key":"pone.0304461.ref035","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.addbeh.2014.02.013","article-title":"Examination of a short English version of the UPPS-P Impulsive Behavior Scale","volume":"39","author":"MA Cyders","year":"2014","journal-title":"Addictive Behaviors"},{"key":"pone.0304461.ref036","doi-asserted-by":"crossref","first-page":"100120","DOI":"10.1016\/j.metip.2023.100120","article-title":"Use and misuse of corrections for multiple testing","volume":"8","author":"MA Garc\u00eda-P\u00e9rez","year":"2023","journal-title":"Methods in Psychology"},{"key":"pone.0304461.ref037","unstructured":"Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders. (1873\u20132402 (Electronic))."},{"issue":"14","key":"pone.0304461.ref038","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.cub.2019.06.034","article-title":"Restless REM Sleep Impedes Overnight Amygdala Adaptation","volume":"29","author":"R Wassing","year":"2019","journal-title":"Curr Biol"},{"key":"pone.0304461.ref039","first-page":"105","volume-title":"Progress in Brain Research","author":"WDS Killgore","year":"2010"},{"issue":"1","key":"pone.0304461.ref040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smrv.2011.03.008","article-title":"Insomnia and daytime cognitive performance: A meta-analysis","volume":"16","author":"\u00c9 Fortier-Brochu","year":"2012","journal-title":"Sleep Medicine Reviews"},{"issue":"12","key":"pone.0304461.ref041","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/da.20751","article-title":"Substance use, childhood traumatic experience, and Posttraumatic Stress Disorder in an urban civilian population","volume":"27","author":"L Khoury","year":"2010","journal-title":"Depress Anxiety"},{"issue":"s1","key":"pone.0304461.ref042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1360-0443.2006.01592.x","article-title":"Comorbidity between substance use disorders and psychiatric conditions","volume":"101","author":"MA Schuckit","year":"2006","journal-title":"Addiction"},{"key":"pone.0304461.ref043","unstructured":"Keyser-Marcus L. RT, Bjork J., Martin C. E., Adams A., Moeller F. G.. Initial validation of a deep phenotyping model for addictions. Under Review."},{"key":"pone.0304461.ref044","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A Decade of Orexin\/Hypocretin and Addiction: Where Are We Now?","volume":"33","author":"MH James","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"issue":"10","key":"pone.0304461.ref045","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"SV Mahler","year":"2014","journal-title":"Nat Neurosci"},{"issue":"447","key":"pone.0304461.ref046","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4953","article-title":"Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy","volume":"10","author":"TC Thannickal","year":"2018","journal-title":"Sci Transl Med"},{"issue":"11","key":"pone.0304461.ref047","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.biopsych.2022.06.027","article-title":"Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction","volume":"92","author":"MH James","year":"2022","journal-title":"Biol Psychiatry"},{"issue":"9","key":"pone.0304461.ref048","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2018.17121383","article-title":"All for One and One for All: Mental Disorders in One Dimension","volume":"175","author":"A Caspi","year":"2018","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"pone.0304461.ref049","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41593-018-0275-1","article-title":"Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders","volume":"21","author":"RK Walters","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"4","key":"pone.0304461.ref050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","article-title":"Identification of a common neurobiological substrate for mental illness","volume":"72","author":"M Goodkind","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"pone.0304461.ref051","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1176\/appi.ajp.2017.16040400","article-title":"Identification of Common Neural Circuit Disruptions in Cognitive Control Across Psychiatric Disorders","volume":"174","author":"LM McTeague","year":"2017","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"pone.0304461.ref052","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41398-022-02028-3","article-title":"The hidden link between circadian entropy and mental health disorders","volume":"12","author":"A Alachkar","year":"2022","journal-title":"Transl Psychiatry"},{"key":"pone.0304461.ref053","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: definition, pitfalls, and adjustment methods","volume":"9","author":"A. Althubaiti","year":"2016","journal-title":"J Multidiscip Healthc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:33:11Z","timestamp":1718299991000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304461"}},"subtitle":[],"editor":[{"given":"Sungwoo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0304461","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}